![Paul Chaplin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Chaplin
Presidente presso
Bavarian Nordic, Inc.
Profilo
Paul Chaplin currently works at Bavarian Nordic A, as President & Chief Executive Officer from 2014, Bavarian Nordic, Inc., as President, and Bavarian Nordic GmbH, as General Manager from 1999.
Dr. Chaplin received his doctorate degree from the University of Bristol.
Ultime notizie su Paul Chaplin
Posizioni attive di Paul Chaplin
| Società | Posizione | Inizio |
|---|---|---|
Bavarian Nordic GmbH
 Bavarian Nordic GmbH BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer and infectious diseases | Corporate Officer/Principal | 03/03/2011 |
Bavarian Nordic, Inc.
 Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and manufactures drugs to treat cancer | Presidente | - |
Precedenti posizioni note di Paul Chaplin
| Società | Posizione | Fine |
|---|---|---|
| BAVARIAN NORDIC A/S | Amministratore Delegato | 15/10/2026 |
Formazione di Paul Chaplin
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
49
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Bavarian Nordic, Inc.
Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and manufactures drugs to treat cancer | Commercial Services |
Bavarian Nordic A/S
 Bavarian Nordic A/S BiotechnologyHealth Technology Engages in research, development and manufacturing travel vaccines | Health Technology |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer and infectious diseases | Health Technology |
